GDTC CytoMed Therapeutics Limited Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

GDTC is expected to report earnings to rise 33.33% to -3 cents per share on November 27

CytoMed Therapeutics Limited GDTC Stock Earnings Reports

Q3'24

Est.

$-0.04

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.04

Q4'23

Est.

$-0.05

Q3'23

Beat

by $0.01

The last earnings report on September 30 showed earnings per share of -2 cents, beating the estimate of -3 cents. With 5.65K shares outstanding, the current market capitalization sits at 24.46M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1 Commonwealth Lane

Phone

+65 62507738

Employees

Web

https://w2.cytomed.sg

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	27.37	0.91	+3.44%
GameStop Corp
AAPL	228.22	3.10	+1.38%
Apple
SPY	593.35	-3.84	-0.64%
SPDR® S&P 500® ETF Trust
BTC.X	87250.430000	-3333.734400	-3.68%
Bitcoin cryptocurrency
TSLA	311.18	-19.06	-5.77%
Tesla

GDTC and Stocks

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

Ticker / NAME	Correlation To GDTC	1D Price Change %
GDTC	100%	-4.50%
CVKD - GDTC	31% Poorly correlated	+0.06%
ADIL - GDTC	30% Poorly correlated	+15.04%
RXRX - GDTC	25% Poorly correlated	-5.60%
CLGN - GDTC	24% Poorly correlated	-1.39%
VALN - GDTC	21% Poorly correlated	-0.20%
More